Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€2.10
19.02.24
-
19.02.25
-10.26%
20.02.24

Risky Investment
Global_Player 
19.02.24 50%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
19.02.24
-
19.02.25
2.41%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
€6.00
31.07.27
-44.67%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
sell
Guideline Geo AB

Start price
Target price
Perf. (%)
€1.30
19.02.24
-
19.02.25
-38.31%
09.05.24

Risky Investment
robertinio 
19.02.24 0%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-24.14%
04.03.24

Risky Investment
robertinio 
19.02.24 0%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€2.69
19.02.24
-
19.02.25
-27.60%
02.04.24

Risky Investment
robertinio 
19.02.24 0%
sell
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
robertinio 
19.02.24 0%
buy
Under Armour Inc. C

Start price
Target price
Perf. (%)
€7.17
18.02.24
€7.00
18.02.25
4.18%
23.02.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
18.02.24 50%
buy
Ferrari NV

Start price
Target price
Perf. (%)
€361.90
18.02.24
€365.00
18.02.25
4.26%
22.02.24

Revenue growth > 30% per year expected
Undervalued
Very Future proof/growth oriented business model
Well known brand
Traumtanz 
18.02.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.01
18.02.24
-
18.02.25
-2.59%
03.03.24

Risky Investment
blaugold 
18.02.24 50%
buy
Achilles Therapeutics Plc

Start price
Target price
Perf. (%)
€0.97
18.02.24
€2.00
31.01.26
0.52%
17.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
18.02.24 60%
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€2.69
17.02.24
€4.00
30.09.25
-18.44%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.02.24 60%
buy
Plastic Omnium S.A.

Start price
Target price
Perf. (%)
€10.44
17.02.24
-
17.02.25
5.56%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 10%
buy
Azelis Group N.v.

Start price
Target price
Perf. (%)
€18.77
17.02.24
-
17.02.25
5.22%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 10%
buy
Adevinta Asa

Start price
Target price
Perf. (%)
€10.03
17.02.24
-
17.02.25
-1.45%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 10%
buy
Cegedim

Start price
Target price
Perf. (%)
€16.78
17.02.24
-
17.02.25
-4.41%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 20%
buy
Factset Research Systems

Start price
Target price
Perf. (%)
€426.80
17.02.24
-
17.02.25
0.52%
02.03.24

Could be worthwhile Investment >10% per year
Leading role in innovation
Strong uniques
knallfrosch44665 
17.02.24 50%
buy
Metavisio (thomson Computing)

Start price
Target price
Perf. (%)
€1.22
17.02.24
-
17.02.25
-19.34%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 0%
buy
2CRSI S.A.

Start price
Target price
Perf. (%)
€5.14
17.02.24
-
17.02.25
-14.98%
02.03.24

Could be worthwhile Investment >10% per year
melinda 
17.02.24 10%
buy
Rheinmetall AG

Start price
Target price
Perf. (%)
€399.90
17.02.24
€400.00
17.02.25
2.83%
23.02.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
positive Cash Flow expected
Good rating
Traumtanz 
17.02.24 50%
buy
Intel Corp.

Start price
Target price
Perf. (%)
€40.75
17.02.24
€42.00
17.02.25
4.53%
04.03.24

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Good rating
Traumtanz 
17.02.24 50%
buy
Intel Corp.

Start price
Target price
Perf. (%)
€16.90
17.02.24
€18.00
17.02.25
3.55%
07.03.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Traumtanz 
17.02.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€3.59
17.02.24
€4.00
17.02.25
3.06%
09.03.24

Good rating
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
17.02.24 50%